Search results for the GEO ID: GSE8546
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM212066
GPL8300
P0075 dexamethasone pre-treatment human myeloma cell P0075 dexamethasone pre-treatment human myeloma cell P0075 dexamethasone pre-treatment human myeloma cell P0075 dexamethasone pre-treatment
GSM212077
GPL8300
P0084 thalidomide pre-treatment human myeloma cell P0084 thalidomide pre-treatment human myeloma cell P0084 thalidomide pre-treatment human myeloma cell P0084 thalidomide pre-treatment
GSM212078
GPL8300
P0099 dexamethasone pre-treatment human myeloma cell P0099 dexamethasone pre-treatment human myeloma cell P0099 dexamethasone pre-treatment human myeloma cell P0099 dexamethasone pre-treatment
GSM212079
GPL8300
P0175 dexamethasone pre-treatment human myeloma cell P0175 dexamethasone pre-treatment human myeloma cell P0175 dexamethasone pre-treatment human myeloma cell P0175 dexamethasone pre-treatment
GSM212080
GPL8300
P0202 thalidomide pre-treatment human myeloma cell P0202 thalidomide pre-treatment human myeloma cell P0202 thalidomide pre-treatment human myeloma cell P0202 thalidomide pre-treatment
GSM212081
GPL8300
P0237 thalidomide pre-treatment human myeloma cell P0237 thalidomide pre-treatment human myeloma cell P0237 thalidomide pre-treatment human myeloma cell P0237 thalidomide pre-treatment
GSM212082
GPL8300
P0239 dexamethasone pre-treatment human myeloma cell P0239 dexamethasone pre-treatment human myeloma cell P0239 dexamethasone pre-treatment human myeloma cell P0239 dexamethasone pre-treatment
GSM212083
GPL8300
P0251 dexamethasone pre-treatment human myeloma cell P0251 dexamethasone pre-treatment human myeloma cell P0251 dexamethasone pre-treatment human myeloma cell P0251 dexamethasone pre-treatment
GSM212084
GPL8300
P0255 thalidomide pre-treatment human myeloma cell P0255 thalidomide pre-treatment human myeloma cell P0255 thalidomide pre-treatment human myeloma cell P0255 thalidomide pre-treatment
GSM212085
GPL8300
P0270 dexamethasone pre-treatment human myeloma cell P0270 dexamethasone pre-treatment human myeloma cell P0270 dexamethasone pre-treatment human myeloma cell P0270 dexamethasone pre-treatment
GSM212086
GPL8300
P0271 thalidomide pre-treatment human myeloma cell P0271 thalidomide pre-treatment human myeloma cell P0271 thalidomide pre-treatment human myeloma cell P0271 thalidomide pre-treatment
GSM212087
GPL8300
P0278 thalidomide pre-treatment human myeloma cell P0278 thalidomide pre-treatment human myeloma cell P0278 thalidomide pre-treatment human myeloma cell P0278 thalidomide pre-treatment
GSM212088
GPL8300
P0280 dexamethasone pre-treatment human myeloma cell P0280 dexamethasone pre-treatment human myeloma cell P0280 dexamethasone pre-treatment human myeloma cell P0280 dexamethasone pre-treatment
GSM212089
GPL8300
P029 thalidomide pre-treatment human myeloma cell P029 thalidomide pre-treatment human myeloma cell P029 thalidomide pre-treatment human myeloma cell P029 thalidomide pre-treatment
GSM212090
GPL8300
P029 thalidomide post-treatment human myeloma cell P029 thalidomide post-treatment human myeloma cell P029 thalidomide post-treatment human myeloma cell P029 thalidomide post-treatment
GSM212091
GPL8300
P0387 dexamethasone pre-treatment human myeloma cell P0387 dexamethasone pre-treatment human myeloma cell P0387 dexamethasone pre-treatment human myeloma cell P0387 dexamethasone pre-treatment
GSM212092
GPL8300
P0465 dexamethasone pre-treatment human myeloma cell P0465 dexamethasone pre-treatment human myeloma cell P0465 dexamethasone pre-treatment human myeloma cell P0465 dexamethasone pre-treatment
GSM212093
GPL8300
P0526 thalidomide post-treatment human myeloma cell P0526 thalidomide post-treatment human myeloma cell P0526 thalidomide post-treatment human myeloma cell P0526 thalidomide post-treatment
GSM212094
GPL8300
P0575 dexamethasone pre-treatment human myeloma cell P0575 dexamethasone pre-treatment human myeloma cell P0575 dexamethasone pre-treatment human myeloma cell P0575 dexamethasone pre-treatment
GSM212095
GPL8300
P0630 dexamethasone pre-treatment human myeloma cell P0630 dexamethasone pre-treatment human myeloma cell P0630 dexamethasone pre-treatment human myeloma cell P0630 dexamethasone pre-treatment
GSM212096
GPL8300
P0636 thalidomide post-treatment human myeloma cell P0636 thalidomide post-treatment human myeloma cell P0636 thalidomide post-treatment human myeloma cell P0636 thalidomide post-treatment
GSM212097
GPL8300
P0640 dexamethasone pre-treatment human myeloma cell P0640 dexamethasone pre-treatment human myeloma cell P0640 dexamethasone pre-treatment human myeloma cell P0640 dexamethasone pre-treatment
GSM212098
GPL8300
P0642 dexamethasone pre-treatment human myeloma cell P0642 dexamethasone pre-treatment human myeloma cell P0642 dexamethasone pre-treatment human myeloma cell P0642 dexamethasone pre-treatment
GSM212099
GPL8300
P0647 thalidomide post-treatment human myeloma cell P0647 thalidomide post-treatment human myeloma cell P0647 thalidomide post-treatment human myeloma cell P0647 thalidomide post-treatment
GSM212100
GPL8300
P0647 thalidomide pre-treatment human myeloma cell P0647 thalidomide pre-treatment human myeloma cell P0647 thalidomide pre-treatment human myeloma cell P0647 thalidomide pre-treatment
GSM212101
GPL8300
P0666 thalidomide post-treatment human myeloma cell P0666 thalidomide post-treatment human myeloma cell P0666 thalidomide post-treatment human myeloma cell P0666 thalidomide post-treatment
GSM212102
GPL8300
P0666 thalidomide pre-treatment human myeloma cell P0666 thalidomide pre-treatment human myeloma cell P0666 thalidomide pre-treatment human myeloma cell P0666 thalidomide pre-treatment
GSM212103
GPL8300
P0667 dexamethasone post-treatment human myeloma cell P0667 dexamethasone post-treatment human myeloma cell P0667 dexamethasone post-treatment human myeloma cell P0667 dexamethasone post-treatment
GSM212104
GPL8300
P0667 dexamethasone pre-treatment human myeloma cell P0667 dexamethasone pre-treatment human myeloma cell P0667 dexamethasone pre-treatment human myeloma cell P0667 dexamethasone pre-treatment
GSM212105
GPL8300
P0670 thalidomide post-treatment human myeloma cell P0670 thalidomide post-treatment human myeloma cell P0670 thalidomide post-treatment human myeloma cell P0670 thalidomide post-treatment
GSM212106
GPL8300
P0670 thalidomide pre-treatment human myeloma cell P0670 thalidomide pre-treatment human myeloma cell P0670 thalidomide pre-treatment human myeloma cell P0670 thalidomide pre-treatment
GSM212107
GPL8300
P0672 dexamethasone post-treatment human myeloma cell P0672 dexamethasone post-treatment human myeloma cell P0672 dexamethasone post-treatment human myeloma cell P0672 dexamethasone post-treatment
GSM212108
GPL8300
P0672 dexamethasone pre-treatment human myeloma cell P0672 dexamethasone pre-treatment human myeloma cell P0672 dexamethasone pre-treatment human myeloma cell P0672 dexamethasone pre-treatment
GSM212109
GPL8300
P0673 thalidomide post-treatment human myeloma cell P0673 thalidomide post-treatment human myeloma cell P0673 thalidomide post-treatment human myeloma cell P0673 thalidomide post-treatment
GSM212110
GPL8300
P0673 thalidomide pre-treatment human myeloma cell P0673 thalidomide pre-treatment human myeloma cell P0673 thalidomide pre-treatment human myeloma cell P0673 thalidomide pre-treatment
GSM212111
GPL8300
P0678 dexamethasone post-treatment human myeloma cell P0678 dexamethasone post-treatment human myeloma cell P0678 dexamethasone post-treatment human myeloma cell P0678 dexamethasone post-treatment
GSM212112
GPL8300
P0678 dexamethasone pre-treatment human myeloma cell P0678 dexamethasone pre-treatment human myeloma cell P0678 dexamethasone pre-treatment human myeloma cell P0678 dexamethasone pre-treatment
GSM212113
GPL8300
P0686 dexamethasone post-treatment human myeloma cell P0686 dexamethasone post-treatment human myeloma cell P0686 dexamethasone post-treatment human myeloma cell P0686 dexamethasone post-treatment
GSM212114
GPL8300
P0686 dexamethasone pre-treatment human myeloma cell P0686 dexamethasone pre-treatment human myeloma cell P0686 dexamethasone pre-treatment human myeloma cell P0686 dexamethasone pre-treatment
GSM212115
GPL8300
P0689 dexamethasone pre-treatment human myeloma cell P0689 dexamethasone pre-treatment human myeloma cell P0689 dexamethasone pre-treatment human myeloma cell P0689 dexamethasone pre-treatment
GSM212116
GPL8300
P0689 dexamethasone post-treatment human myeloma cell P0689 dexamethasone post-treatment human myeloma cell P0689 dexamethasone post-treatment human myeloma cell P0689 dexamethasone post-treatment
GSM212117
GPL8300
P0692 thalidomide post-treatment human myeloma cell P0692 thalidomide post-treatment human myeloma cell P0692 thalidomide post-treatment human myeloma cell P0692 thalidomide post-treatment
GSM212118
GPL8300
P0692 thalidomide pre-treatment human myeloma cell P0692 thalidomide pre-treatment human myeloma cell P0692 thalidomide pre-treatment human myeloma cell P0692 thalidomide pre-treatment
GSM212119
GPL8300
P0695 thalidomide post-treatment human myeloma cell P0695 thalidomide post-treatment human myeloma cell P0695 thalidomide post-treatment human myeloma cell P0695 thalidomide post-treatment
GSM212120
GPL8300
P0695 thalidomide pre-treatment human myeloma cell P0695 thalidomide pre-treatment human myeloma cell P0695 thalidomide pre-treatment human myeloma cell P0695 thalidomide pre-treatment
GSM212121
GPL8300
P0698 thalidomide post-treatment human myeloma cell P0698 thalidomide post-treatment human myeloma cell P0698 thalidomide post-treatment human myeloma cell P0698 thalidomide post-treatment
GSM212122
GPL8300
P0698 thalidomide pre-treatment human myeloma cell P0698 thalidomide pre-treatment human myeloma cell P0698 thalidomide pre-treatment human myeloma cell P0698 thalidomide pre-treatment
GSM212123
GPL8300
P0702 thalidomide post-treatment human myeloma cell P0702 thalidomide post-treatment human myeloma cell P0702 thalidomide post-treatment human myeloma cell P0702 thalidomide post-treatment
GSM212124
GPL8300
P0702 thalidomide pre-treatment human myeloma cell P0702 thalidomide pre-treatment human myeloma cell P0702 thalidomide pre-treatment human myeloma cell P0702 thalidomide pre-treatment
GSM212125
GPL8300
P0705 thalidomide post-treatment human myeloma cell P0705 thalidomide post-treatment human myeloma cell P0705 thalidomide post-treatment human myeloma cell P0705 thalidomide post-treatment
GSM212126
GPL8300
P0705 thalidomide pre-treatment human myeloma cell P0705 thalidomide pre-treatment human myeloma cell P0705 thalidomide pre-treatment human myeloma cell P0705 thalidomide pre-treatment
GSM212127
GPL8300
P0718 thalidomide post-treatment human myeloma cell P0718 thalidomide post-treatment human myeloma cell P0718 thalidomide post-treatment human myeloma cell P0718 thalidomide post-treatment
GSM212128
GPL8300
P0718 thalidomide pre-treatment human myeloma cell P0718 thalidomide pre-treatment human myeloma cell P0718 thalidomide pre-treatment human myeloma cell P0718 thalidomide pre-treatment
GSM212129
GPL8300
P0724 dexamethasone post-treatment human myeloma cell P0724 dexamethasone post-treatment human myeloma cell P0724 dexamethasone post-treatment human myeloma cell P0724 dexamethasone post-treatment
GSM212130
GPL8300
P0724 dexamethasone pre-treatment human myeloma cell P0724 dexamethasone pre-treatment human myeloma cell P0724 dexamethasone pre-treatment human myeloma cell P0724 dexamethasone pre-treatment
GSM212131
GPL8300
P0725 dexamethasone post-treatment human myeloma cell P0725 dexamethasone post-treatment human myeloma cell P0725 dexamethasone post-treatment human myeloma cell P0725 dexamethasone post-treatment
GSM212132
GPL8300
P0725 dexamethasone pre-treatment human myeloma cell P0725 dexamethasone pre-treatment human myeloma cell P0725 dexamethasone pre-treatment human myeloma cell P0725 dexamethasone pre-treatment
GSM212133
GPL8300
P0733 dexamethasone post-treatment human myeloma cell P0733 dexamethasone post-treatment human myeloma cell P0733 dexamethasone post-treatment human myeloma cell P0733 dexamethasone post-treatment
GSM212134
GPL8300
P0733 dexamethasone pre-treatment human myeloma cell P0733 dexamethasone pre-treatment human myeloma cell P0733 dexamethasone pre-treatment human myeloma cell P0733 dexamethasone pre-treatment
GSM212135
GPL8300
P0740 dexamethasone post-treatment human myeloma cell P0740 dexamethasone post-treatment human myeloma cell P0740 dexamethasone post-treatment human myeloma cell P0740 dexamethasone post-treatment
GSM212136
GPL8300
P0740 dexamethasone pre-treatment human myeloma cell P0740 dexamethasone pre-treatment human myeloma cell P0740 dexamethasone pre-treatment human myeloma cell P0740 dexamethasone pre-treatment
GSM212137
GPL8300
P0741 dexamethasone post-treatment human myeloma cell P0741 dexamethasone post-treatment human myeloma cell P0741 dexamethasone post-treatment human myeloma cell P0741 dexamethasone post-treatment
GSM212138
GPL8300
P0741 dexamethasone pre-treatment human myeloma cell P0741 dexamethasone pre-treatment human myeloma cell P0741 dexamethasone pre-treatment human myeloma cell P0741 dexamethasone pre-treatment
GSM212139
GPL8300
P075 dexamethasone post-treatment human myeloma cell P075 dexamethasone post-treatment human myeloma cell P075 dexamethasone post-treatment human myeloma cell P075 dexamethasone post-treatment
GSM212140
GPL8300
P084 thalidomide post-treatment human myeloma cell P084 thalidomide post-treatment human myeloma cell P084 thalidomide post-treatment human myeloma cell P084 thalidomide post-treatment
GSM212141
GPL8300
P095 dexamethasone post-treatment human myeloma cell P095 dexamethasone post-treatment human myeloma cell P095 dexamethasone post-treatment human myeloma cell P095 dexamethasone post-treatment
GSM212142
GPL8300
P095 dexamethasone pre-treatment human myeloma cell P095 dexamethasone pre-treatment human myeloma cell P095 dexamethasone pre-treatment human myeloma cell P095 dexamethasone pre-treatment
GSM212143
GPL8300
P099 dexamethasone post-treatment human myeloma cell P099 dexamethasone post-treatment human myeloma cell P099 dexamethasone post-treatment human myeloma cell P099 dexamethasone post-treatment
GSM212144
GPL8300
P154 thalidomide post-treatment human myeloma cell P154 thalidomide post-treatment human myeloma cell P154 thalidomide post-treatment human myeloma cell P154 thalidomide post-treatment
GSM212145
GPL8300
P154 thalidomide pre-treatment human myeloma cell P154 thalidomide pre-treatment human myeloma cell P154 thalidomide pre-treatment human myeloma cell P154 thalidomide pre-treatment
GSM212146
GPL8300
P175 dexamethasone post-treatment human myeloma cell P175 dexamethasone post-treatment human myeloma cell P175 dexamethasone post-treatment human myeloma cell P175 dexamethasone post-treatment
GSM212147
GPL8300
P202 thalidomide post-treatment human myeloma cell P202 thalidomide post-treatment human myeloma cell P202 thalidomide post-treatment human myeloma cell P202 thalidomide post-treatment
GSM212148
GPL8300
P232 thalidomide post-treatment human myeloma cell P232 thalidomide post-treatment human myeloma cell P232 thalidomide post-treatment human myeloma cell P232 thalidomide post-treatment
GSM212149
GPL8300
P232 thalidomide pre-treatment human myeloma cell P232 thalidomide pre-treatment human myeloma cell P232 thalidomide pre-treatment human myeloma cell P232 thalidomide pre-treatment
GSM212150
GPL8300
P237 thalidomide post-treatment human myeloma cell P237 thalidomide post-treatment human myeloma cell P237 thalidomide post-treatment human myeloma cell P237 thalidomide post-treatment
GSM212151
GPL8300
P239 dexamethasone post-treatment human myeloma cell P239 dexamethasone post-treatment human myeloma cell P239 dexamethasone post-treatment human myeloma cell P239 dexamethasone post-treatment
GSM212152
GPL8300
P251 dexamethasone post-treatment human myeloma cell P251 dexamethasone post-treatment human myeloma cell P251 dexamethasone post-treatment human myeloma cell P251 dexamethasone post-treatment
GSM212153
GPL8300
P255 thalidomide post-treatment human myeloma cell P255 thalidomide post-treatment human myeloma cell P255 thalidomide post-treatment human myeloma cell P255 thalidomide post-treatment
GSM212154
GPL8300
P270 dexamethasone post-treatment human myeloma cell P270 dexamethasone post-treatment human myeloma cell P270 dexamethasone post-treatment human myeloma cell P270 dexamethasone post-treatment
GSM212155
GPL8300
P271 thalidomide post-treatment human myeloma cell P271 thalidomide post-treatment human myeloma cell P271 thalidomide post-treatment human myeloma cell P271 thalidomide post-treatment
GSM212156
GPL8300
P278 thalidomide post-treatment human myeloma cell P278 thalidomide post-treatment human myeloma cell P278 thalidomide post-treatment human myeloma cell P278 thalidomide post-treatment
GSM212157
GPL8300
P280 dexamethasone post-treatment human myeloma cell P280 dexamethasone post-treatment human myeloma cell P280 dexamethasone post-treatment human myeloma cell P280 dexamethasone post-treatment
GSM212158
GPL8300
P281 thalidomide pre-treatment human myeloma cell P281 thalidomide pre-treatment human myeloma cell P281 thalidomide pre-treatment human myeloma cell P281 thalidomide pre-treatment
GSM212159
GPL8300
P281 thalidomide post-treatment human myeloma cell P281 thalidomide post-treatment human myeloma cell P281 thalidomide post-treatment human myeloma cell P281 thalidomide post-treatment
GSM212160
GPL8300
P301 thalidomide post-treatment human myeloma cell P301 thalidomide post-treatment human myeloma cell P301 thalidomide post-treatment human myeloma cell P301 thalidomide post-treatment
GSM212161
GPL8300
P301 thalidomide pre-treatment human myeloma cell P301 thalidomide pre-treatment human myeloma cell P301 thalidomide pre-treatment human myeloma cell P301 thalidomide pre-treatment
GSM212162
GPL8300
P308 dexamethasone post-treatment human myeloma cell P308 dexamethasone post-treatment human myeloma cell P308 dexamethasone post-treatment human myeloma cell P308 dexamethasone post-treatment
GSM212163
GPL8300
P308 dexamethasone pre-treatment human myeloma cell P308 dexamethasone pre-treatment human myeloma cell P308 dexamethasone pre-treatment human myeloma cell P308 dexamethasone pre-treatment
GSM212164
GPL8300
P313 dexamethasone post-treatment human myeloma cell P313 dexamethasone post-treatment human myeloma cell P313 dexamethasone post-treatment human myeloma cell P313 dexamethasone post-treatment
GSM212165
GPL8300
P313 dexamethasone pre-treatment human myeloma cell P313 dexamethasone pre-treatment human myeloma cell P313 dexamethasone pre-treatment human myeloma cell P313 dexamethasone pre-treatment
GSM212166
GPL8300
P324 thalidomide post-treatment human myeloma cell P324 thalidomide post-treatment human myeloma cell P324 thalidomide post-treatment human myeloma cell P324 thalidomide post-treatment
GSM212167
GPL8300
P324 thalidomide pre-treatment human myeloma cell P324 thalidomide pre-treatment human myeloma cell P324 thalidomide pre-treatment human myeloma cell P324 thalidomide pre-treatment
GSM212168
GPL8300
P330 thalidomide post-treatment human myeloma cell P330 thalidomide post-treatment human myeloma cell P330 thalidomide post-treatment human myeloma cell P330 thalidomide post-treatment
GSM212169
GPL8300
P330 thalidomide pre-treatment human myeloma cell P330 thalidomide pre-treatment human myeloma cell P330 thalidomide pre-treatment human myeloma cell P330 thalidomide pre-treatment
GSM212170
GPL8300
P343 dexamethasone pre-treatment human myeloma cell P343 dexamethasone pre-treatment human myeloma cell P343 dexamethasone pre-treatment human myeloma cell P343 dexamethasone pre-treatment
GSM212171
GPL8300
P343 dexamethasone post-treatment human myeloma cell P343 dexamethasone post-treatment human myeloma cell P343 dexamethasone post-treatment human myeloma cell P343 dexamethasone post-treatment
GSM212172
GPL8300
P354 dexamethasone pre-treatment human myeloma cell P354 dexamethasone pre-treatment human myeloma cell P354 dexamethasone pre-treatment human myeloma cell P354 dexamethasone pre-treatment
GSM212173
GPL8300
P354 dexamethasone post-treatment human myeloma cell P354 dexamethasone post-treatment human myeloma cell P354 dexamethasone post-treatment human myeloma cell P354 dexamethasone post-treatment
GSM212174
GPL8300
P357 thalidomide pre-treatment human myeloma cell P357 thalidomide pre-treatment human myeloma cell P357 thalidomide pre-treatment human myeloma cell P357 thalidomide pre-treatment
GSM212175
GPL8300
P357 thalidomide post-treatment human myeloma cell P357 thalidomide post-treatment human myeloma cell P357 thalidomide post-treatment human myeloma cell P357 thalidomide post-treatment
GSM212176
GPL8300
P365 thalidomide pre-treatment human myeloma cell P365 thalidomide pre-treatment human myeloma cell P365 thalidomide pre-treatment human myeloma cell P365 thalidomide pre-treatment
GSM212177
GPL8300
P365 thalidomide post-treatment human myeloma cell P365 thalidomide post-treatment human myeloma cell P365 thalidomide post-treatment human myeloma cell P365 thalidomide post-treatment
GSM212179
GPL8300
P371 dexamethasone post-treatment human myeloma cell P371 dexamethasone post-treatment human myeloma cell P371 dexamethasone post-treatment human myeloma cell P371 dexamethasone post-treatment
GSM212180
GPL8300
P387 dexamethasone post-treatment human myeloma cell P387 dexamethasone post-treatment human myeloma cell P387 dexamethasone post-treatment human myeloma cell P387 dexamethasone post-treatment
GSM212181
GPL8300
P391 thalidomide pre-treatment human myeloma cell P391 thalidomide pre-treatment human myeloma cell P391 thalidomide pre-treatment human myeloma cell P391 thalidomide pre-treatment
GSM212182
GPL8300
P391 thalidomide post-treatment human myeloma cell P391 thalidomide post-treatment human myeloma cell P391 thalidomide post-treatment human myeloma cell P391 thalidomide post-treatment
GSM212183
GPL8300
P399 thalidomide pre-treatment human myeloma cell P399 thalidomide pre-treatment human myeloma cell P399 thalidomide pre-treatment human myeloma cell P399 thalidomide pre-treatment
GSM212184
GPL8300
P399 thalidomide post-treatment human myeloma cell P399 thalidomide post-treatment human myeloma cell P399 thalidomide post-treatment human myeloma cell P399 thalidomide post-treatment
GSM212185
GPL8300
P405 dexamethasone pre-treatment human myeloma cell P405 dexamethasone pre-treatment human myeloma cell P405 dexamethasone pre-treatment human myeloma cell P405 dexamethasone pre-treatment
GSM212186
GPL8300
P405 dexamethasone post-treatment human myeloma cell P405 dexamethasone post-treatment human myeloma cell P405 dexamethasone post-treatment human myeloma cell P405 dexamethasone post-treatment
GSM212187
GPL8300
P421 thalidomide pre-treatment human myeloma cell P421 thalidomide pre-treatment human myeloma cell P421 thalidomide pre-treatment human myeloma cell P421 thalidomide pre-treatment
GSM212188
GPL8300
P421 thalidomide post-treatment human myeloma cell P421 thalidomide post-treatment human myeloma cell P421 thalidomide post-treatment human myeloma cell P421 thalidomide post-treatment
GSM212189
GPL8300
P433 dexamethasone pre-treatment human myeloma cell P433 dexamethasone pre-treatment human myeloma cell P433 dexamethasone pre-treatment human myeloma cell P433 dexamethasone pre-treatment
GSM212190
GPL8300
P433 dexamethasone post-treatment human myeloma cell P433 dexamethasone post-treatment human myeloma cell P433 dexamethasone post-treatment human myeloma cell P433 dexamethasone post-treatment
GSM212191
GPL8300
P434 dexamethasone pre-treatment human myeloma cell P434 dexamethasone pre-treatment human myeloma cell P434 dexamethasone pre-treatment human myeloma cell P434 dexamethasone pre-treatment
GSM212192
GPL8300
P434 dexamethasone post-treatment human myeloma cell P434 dexamethasone post-treatment human myeloma cell P434 dexamethasone post-treatment human myeloma cell P434 dexamethasone post-treatment
GSM212193
GPL8300
P447 dexamethasone pre-treatment human myeloma cell P447 dexamethasone pre-treatment human myeloma cell P447 dexamethasone pre-treatment human myeloma cell P447 dexamethasone pre-treatment
GSM212194
GPL8300
P447 dexamethasone post-treatment human myeloma cell P447 dexamethasone post-treatment human myeloma cell P447 dexamethasone post-treatment human myeloma cell P447 dexamethasone post-treatment
GSM212195
GPL8300
P451 thalidomide pre-treatment human myeloma cell P451 thalidomide pre-treatment human myeloma cell P451 thalidomide pre-treatment human myeloma cell P451 thalidomide pre-treatment
GSM212196
GPL8300
P451 thalidomide post-treatment human myeloma cell P451 thalidomide post-treatment human myeloma cell P451 thalidomide post-treatment human myeloma cell P451 thalidomide post-treatment
GSM212197
GPL8300
P465 dexamethasone post-treatment human myeloma cell P465 dexamethasone post-treatment human myeloma cell P465 dexamethasone post-treatment human myeloma cell P465 dexamethasone post-treatment
GSM212198
GPL8300
P474 thalidomide pre-treatment human myeloma cell P474 thalidomide pre-treatment human myeloma cell P474 thalidomide pre-treatment human myeloma cell P474 thalidomide pre-treatment
GSM212199
GPL8300
P474 thalidomide post-treatment human myeloma cell P474 thalidomide post-treatment human myeloma cell P474 thalidomide post-treatment human myeloma cell P474 thalidomide post-treatment
GSM212200
GPL8300
P480 dexamethasone pre-treatment human myeloma cell P480 dexamethasone pre-treatment human myeloma cell P480 dexamethasone pre-treatment human myeloma cell P480 dexamethasone pre-treatment
GSM212201
GPL8300
P480 dexamethasone post-treatment human myeloma cell P480 dexamethasone post-treatment human myeloma cell P480 dexamethasone post-treatment human myeloma cell P480 dexamethasone post-treatment
GSM212202
GPL8300
P482 dexamethasone pre-treatment human myeloma cell P482 dexamethasone pre-treatment human myeloma cell P482 dexamethasone pre-treatment human myeloma cell P482 dexamethasone pre-treatment
GSM212204
GPL8300
P492 thalidomide pre-treatment human myeloma cell P492 thalidomide pre-treatment human myeloma cell P492 thalidomide pre-treatment human myeloma cell P492 thalidomide pre-treatment
GSM212205
GPL8300
P492 thalidomide post-treatment human myeloma cell P492 thalidomide post-treatment human myeloma cell P492 thalidomide post-treatment human myeloma cell P492 thalidomide post-treatment
GSM212206
GPL8300
P501 dexamethasone pre-treatment human myeloma cell P501 dexamethasone pre-treatment human myeloma cell P501 dexamethasone pre-treatment human myeloma cell P501 dexamethasone pre-treatment
GSM212207
GPL8300
P501 dexamethasone post-treatment human myeloma cell P501 dexamethasone post-treatment human myeloma cell P501 dexamethasone post-treatment human myeloma cell P501 dexamethasone post-treatment
GSM212208
GPL8300
P503 dexamethasone pre-treatment human myeloma cell P503 dexamethasone pre-treatment human myeloma cell P503 dexamethasone pre-treatment human myeloma cell P503 dexamethasone pre-treatment
GSM212209
GPL8300
P503 dexamethasone post-treatment human myeloma cell P503 dexamethasone post-treatment human myeloma cell P503 dexamethasone post-treatment human myeloma cell P503 dexamethasone post-treatment
GSM212210
GPL8300
P508 thalidomide pre-treatment human myeloma cell P508 thalidomide pre-treatment human myeloma cell P508 thalidomide pre-treatment human myeloma cell P508 thalidomide pre-treatment
GSM212211
GPL8300
P508 thalidomide post-treatment human myeloma cell P508 thalidomide post-treatment human myeloma cell P508 thalidomide post-treatment human myeloma cell P508 thalidomide post-treatment
GSM212212
GPL8300
P510 dexamethasone pre-treatment human myeloma cell P510 dexamethasone pre-treatment human myeloma cell P510 dexamethasone pre-treatment human myeloma cell P510 dexamethasone pre-treatment
GSM212213
GPL8300
P510 dexamethasone post-treatment human myeloma cell P510 dexamethasone post-treatment human myeloma cell P510 dexamethasone post-treatment human myeloma cell P510 dexamethasone post-treatment
GSM212214
GPL8300
P511 dexamethasone pre-treatment human myeloma cell P511 dexamethasone pre-treatment human myeloma cell P511 dexamethasone pre-treatment human myeloma cell P511 dexamethasone pre-treatment
GSM212215
GPL8300
P511 dexamethasone post-treatment human myeloma cell P511 dexamethasone post-treatment human myeloma cell P511 dexamethasone post-treatment human myeloma cell P511 dexamethasone post-treatment
GSM212217
GPL8300
P517 dexamethasone post-treatment human myeloma cell P517 dexamethasone post-treatment human myeloma cell P517 dexamethasone post-treatment human myeloma cell P517 dexamethasone post-treatment
GSM212218
GPL8300
P522 dexamethasone pre-treatment human myeloma cell P522 dexamethasone pre-treatment human myeloma cell P522 dexamethasone pre-treatment human myeloma cell P522 dexamethasone pre-treatment
GSM212219
GPL8300
P522 dexamethasone post-treatment human myeloma cell P522 dexamethasone post-treatment human myeloma cell P522 dexamethasone post-treatment human myeloma cell P522 dexamethasone post-treatment
GSM212220
GPL8300
P526 thalidomide pre-treatment human myeloma cell P526 thalidomide pre-treatment human myeloma cell P526 thalidomide pre-treatment human myeloma cell P526 thalidomide pre-treatment
GSM212221
GPL8300
P532 dexamethasone pre-treatment human myeloma cell P532 dexamethasone pre-treatment human myeloma cell P532 dexamethasone pre-treatment human myeloma cell P532 dexamethasone pre-treatment
GSM212222
GPL8300
P532 dexamethasone post-treatment human myeloma cell P532 dexamethasone post-treatment human myeloma cell P532 dexamethasone post-treatment human myeloma cell P532 dexamethasone post-treatment
GSM212223
GPL8300
P541 thalidomide pre-treatment human myeloma cell P541 thalidomide pre-treatment human myeloma cell P541 thalidomide pre-treatment human myeloma cell P541 thalidomide pre-treatment
GSM212224
GPL8300
P541 thalidomide post-treatment human myeloma cell P541 thalidomide post-treatment human myeloma cell P541 thalidomide post-treatment human myeloma cell P541 thalidomide post-treatment
GSM212225
GPL8300
P549 dexamethasone pre-treatment human myeloma cell P549 dexamethasone pre-treatment human myeloma cell P549 dexamethasone pre-treatment human myeloma cell P549 dexamethasone pre-treatment
GSM212226
GPL8300
P549 dexamethasone post-treatment human myeloma cell P549 dexamethasone post-treatment human myeloma cell P549 dexamethasone post-treatment human myeloma cell P549 dexamethasone post-treatment
GSM212229
GPL8300
P561 thalidomide pre-treatment human myeloma cell P561 thalidomide pre-treatment human myeloma cell P561 thalidomide pre-treatment human myeloma cell P561 thalidomide pre-treatment
GSM212230
GPL8300
P561 thalidomide post-treatment human myeloma cell P561 thalidomide post-treatment human myeloma cell P561 thalidomide post-treatment human myeloma cell P561 thalidomide post-treatment
GSM212231
GPL8300
P566 dexamethasone pre-treatment human myeloma cell P566 dexamethasone pre-treatment human myeloma cell P566 dexamethasone pre-treatment human myeloma cell P566 dexamethasone pre-treatment
GSM212232
GPL8300
P566 dexamethasone post-treatment human myeloma cell P566 dexamethasone post-treatment human myeloma cell P566 dexamethasone post-treatment human myeloma cell P566 dexamethasone post-treatment
GSM212233
GPL8300
P575 dexamethasone post-treatment human myeloma cell P575 dexamethasone post-treatment human myeloma cell P575 dexamethasone post-treatment human myeloma cell P575 dexamethasone post-treatment
GSM212234
GPL8300
P594 thalidomide pre-treatment human myeloma cell P594 thalidomide pre-treatment human myeloma cell P594 thalidomide pre-treatment human myeloma cell P594 thalidomide pre-treatment
GSM212235
GPL8300
P594 thalidomide post-treatment human myeloma cell P594 thalidomide post-treatment human myeloma cell P594 thalidomide post-treatment human myeloma cell P594 thalidomide post-treatment
GSM212236
GPL8300
P597 thalidomide pre-treatment human myeloma cell P597 thalidomide pre-treatment human myeloma cell P597 thalidomide pre-treatment human myeloma cell P597 thalidomide pre-treatment
GSM212237
GPL8300
P597 thalidomide post-treatment human myeloma cell P597 thalidomide post-treatment human myeloma cell P597 thalidomide post-treatment human myeloma cell P597 thalidomide post-treatment
GSM212238
GPL8300
P600 thalidomide pre-treatment human myeloma cell P600 thalidomide pre-treatment human myeloma cell P600 thalidomide pre-treatment human myeloma cell P600 thalidomide pre-treatment
GSM212239
GPL8300
P600 thalidomide post-treatment human myeloma cell P600 thalidomide post-treatment human myeloma cell P600 thalidomide post-treatment human myeloma cell P600 thalidomide post-treatment
GSM212240
GPL8300
P610 thalidomide pre-treatment human myeloma cell P610 thalidomide pre-treatment human myeloma cell P610 thalidomide pre-treatment human myeloma cell P610 thalidomide pre-treatment
GSM212241
GPL8300
P610 thalidomide post-treatment human myeloma cell P610 thalidomide post-treatment human myeloma cell P610 thalidomide post-treatment human myeloma cell P610 thalidomide post-treatment
GSM212242
GPL8300
P614 thalidomide pre-treatment human myeloma cell P614 thalidomide pre-treatment human myeloma cell P614 thalidomide pre-treatment human myeloma cell P614 thalidomide pre-treatment
GSM212243
GPL8300
P614 thalidomide post-treatment human myeloma cell P614 thalidomide post-treatment human myeloma cell P614 thalidomide post-treatment human myeloma cell P614 thalidomide post-treatment
GSM212244
GPL8300
P625 dexamethasone pre-treatment human myeloma cell P625 dexamethasone pre-treatment human myeloma cell P625 dexamethasone pre-treatment human myeloma cell P625 dexamethasone pre-treatment
GSM212245
GPL8300
P625 dexamethasone post-treatment human myeloma cell P625 dexamethasone post-treatment human myeloma cell P625 dexamethasone post-treatment human myeloma cell P625 dexamethasone post-treatment
GSM212246
GPL8300
P630 dexamethasone post-treatment human myeloma cell P630 dexamethasone post-treatment human myeloma cell P630 dexamethasone post-treatment human myeloma cell P630 dexamethasone post-treatment
GSM212247
GPL8300
P636 thalidomide pre-treatment human myeloma cell P636 thalidomide pre-treatment human myeloma cell P636 thalidomide pre-treatment human myeloma cell P636 thalidomide pre-treatment
GSM212248
GPL8300
P640 dexamethasone post-treatment human myeloma cell P640 dexamethasone post-treatment human myeloma cell P640 dexamethasone post-treatment human myeloma cell P640 dexamethasone post-treatment
GSM212249
GPL8300
P642 dexamethasone post-treatment human myeloma cell P642 dexamethasone post-treatment human myeloma cell P642 dexamethasone post-treatment human myeloma cell P642 dexamethasone post-treatment
GSM212250
GPL8300
P580 lenalidomide pre-treatment human myeloma cell P580 lenalidomide pre-treatment human myeloma cell P580 lenalidomide pre-treatment human myeloma cell P580 lenalidomide pre-treatment
GSM212251
GPL8300
P558 lenalidomide pre-treatment human myeloma cell P558 lenalidomide pre-treatment human myeloma cell P558 lenalidomide pre-treatment human myeloma cell P558 lenalidomide pre-treatment
GSM212252
GPL8300
P0764 lenalidomide pre-treatment human myeloma cell P0764 lenalidomide pre-treatment human myeloma cell P0764 lenalidomide pre-treatment human myeloma cell P0764 lenalidomide pre-treatment
GSM212253
GPL8300
P621 lenalidomide pre-treatment human myeloma cell P621 lenalidomide pre-treatment human myeloma cell P621 lenalidomide pre-treatment human myeloma cell P621 lenalidomide pre-treatment
GSM212254
GPL8300
P557 lenalidomide pre-treatment human myeloma cell P557 lenalidomide pre-treatment human myeloma cell P557 lenalidomide pre-treatment human myeloma cell P557 lenalidomide pre-treatment
GSM212255
GPL8300
P547 lenalidomide pre-treatment human myeloma cell P547 lenalidomide pre-treatment human myeloma cell P547 lenalidomide pre-treatment human myeloma cell P547 lenalidomide pre-treatment
GSM212256
GPL8300
P543 lenalidomide post-treatment human myeloma cell P543 lenalidomide post-treatment human myeloma cell P543 lenalidomide post-treatment human myeloma cell P543 lenalidomide post-treatment
GSM212257
GPL8300
P617 lenalidomide post-treatment human myeloma cell P617 lenalidomide post-treatment human myeloma cell P617 lenalidomide post-treatment human myeloma cell P617 lenalidomide post-treatment
GSM212258
GPL8300
P0677 lenalidomide post-treatment human myeloma cell P0677 lenalidomide post-treatment human myeloma cell P0677 lenalidomide post-treatment human myeloma cell P0677 lenalidomide post-treatment
GSM212259
GPL8300
P519 lenalidomide post-treatment human myeloma cell P519 lenalidomide post-treatment human myeloma cell P519 lenalidomide post-treatment human myeloma cell P519 lenalidomide post-treatment
GSM212260
GPL8300
P516 lenalidomide pre-treatment human myeloma cell P516 lenalidomide pre-treatment human myeloma cell P516 lenalidomide pre-treatment human myeloma cell P516 lenalidomide pre-treatment
GSM212261
GPL8300
P0716 lenalidomide pre-treatment human myeloma cell P0716 lenalidomide pre-treatment human myeloma cell P0716 lenalidomide pre-treatment human myeloma cell P0716 lenalidomide pre-treatment
GSM212262
GPL8300
P336 lenalidomide pre-treatment human myeloma cell P336 lenalidomide pre-treatment human myeloma cell P336 lenalidomide pre-treatment human myeloma cell P336 lenalidomide pre-treatment
GSM212264
GPL8300
P619 lenalidomide pre-treatment human myeloma cell P619 lenalidomide pre-treatment human myeloma cell P619 lenalidomide pre-treatment human myeloma cell P619 lenalidomide pre-treatment
GSM212265
GPL8300
P499 lenalidomide pre-treatment human myeloma cell P499 lenalidomide pre-treatment human myeloma cell P499 lenalidomide pre-treatment human myeloma cell P499 lenalidomide pre-treatment
GSM212266
GPL8300
P555 lenalidomide pre-treatment human myeloma cell P555 lenalidomide pre-treatment human myeloma cell P555 lenalidomide pre-treatment human myeloma cell P555 lenalidomide pre-treatment
GSM212267
GPL8300
P072 lenalidomide pre-treatment human myeloma cell P072 lenalidomide pre-treatment human myeloma cell P072 lenalidomide pre-treatment human myeloma cell P072 lenalidomide pre-treatment
GSM212268
GPL8300
P590 lenalidomide pre-treatment human myeloma cell P590 lenalidomide pre-treatment human myeloma cell P590 lenalidomide pre-treatment human myeloma cell P590 lenalidomide pre-treatment
GSM212270
GPL8300
P72 lenalidomide post-treatment human myeloma cell P72 lenalidomide post-treatment human myeloma cell P72 lenalidomide post-treatment human myeloma cell P72 lenalidomide post-treatment
GSM212271
GPL8300
P554 lenalidomide pre-treatment human myeloma cell P554 lenalidomide pre-treatment human myeloma cell P554 lenalidomide pre-treatment human myeloma cell P554 lenalidomide pre-treatment
GSM212272
GPL8300
P244 lenalidomide pre_Cycle_3_Dex-treatment human myeloma cell P244 lenalidomide pre_Cycle_3_Dex-treatment human myeloma cell P244 lenalidomide pre_Cycle_3_Dex-treatment human myeloma cell P244 lenalidomide pre_Cycle_3_Dex-treatment
GSM212273
GPL8300
P0619 lenalidomide pre-treatment human myeloma cell P0619 lenalidomide pre-treatment human myeloma cell P0619 lenalidomide pre-treatment human myeloma cell P0619 lenalidomide pre-treatment
GSM212274
GPL8300
P580 lenalidomide post-treatment human myeloma cell P580 lenalidomide post-treatment human myeloma cell P580 lenalidomide post-treatment human myeloma cell P580 lenalidomide post-treatment
GSM212275
GPL8300
P543 lenalidomide pre-treatment human myeloma cell P543 lenalidomide pre-treatment human myeloma cell P543 lenalidomide pre-treatment human myeloma cell P543 lenalidomide pre-treatment
GSM212276
GPL8300
P509 lenalidomide pre-treatment human myeloma cell P509 lenalidomide pre-treatment human myeloma cell P509 lenalidomide pre-treatment human myeloma cell P509 lenalidomide pre-treatment
GSM212277
GPL8300
P557 lenalidomide post-treatment human myeloma cell P557 lenalidomide post-treatment human myeloma cell P557 lenalidomide post-treatment human myeloma cell P557 lenalidomide post-treatment
GSM212278
GPL8300
P486 lenalidomide pre-treatment human myeloma cell P486 lenalidomide pre-treatment human myeloma cell P486 lenalidomide pre-treatment human myeloma cell P486 lenalidomide pre-treatment
GSM212279
GPL8300
P336 lenalidomide post-treatment human myeloma cell P336 lenalidomide post-treatment human myeloma cell P336 lenalidomide post-treatment human myeloma cell P336 lenalidomide post-treatment
GSM212280
GPL8300
P244 lenalidomide pre-treatment human myeloma cell P244 lenalidomide pre-treatment human myeloma cell P244 lenalidomide pre-treatment human myeloma cell P244 lenalidomide pre-treatment
GSM212281
GPL8300
P0662 lenalidomide pre-treatment human myeloma cell P0662 lenalidomide pre-treatment human myeloma cell P0662 lenalidomide pre-treatment human myeloma cell P0662 lenalidomide pre-treatment
GSM212282
GPL8300
P621 lenalidomide post-treatment human myeloma cell P621 lenalidomide post-treatment human myeloma cell P621 lenalidomide post-treatment human myeloma cell P621 lenalidomide post-treatment
GSM212283
GPL8300
P548 lenalidomide post-treatment human myeloma cell P548 lenalidomide post-treatment human myeloma cell P548 lenalidomide post-treatment human myeloma cell P548 lenalidomide post-treatment
GSM212284
GPL8300
P555 lenalidomide post-treatment human myeloma cell P555 lenalidomide post-treatment human myeloma cell P555 lenalidomide post-treatment human myeloma cell P555 lenalidomide post-treatment
GSM212285
GPL8300
P0716 lenalidomide post-treatment human myeloma cell P0716 lenalidomide post-treatment human myeloma cell P0716 lenalidomide post-treatment human myeloma cell P0716 lenalidomide post-treatment
GSM212287
GPL8300
P617 lenalidomide pre-treatment human myeloma cell P617 lenalidomide pre-treatment human myeloma cell P617 lenalidomide pre-treatment human myeloma cell P617 lenalidomide pre-treatment
GSM212288
GPL8300
P616 lenalidomide pre-treatment human myeloma cell P616 lenalidomide pre-treatment human myeloma cell P616 lenalidomide pre-treatment human myeloma cell P616 lenalidomide pre-treatment
GSM212289
GPL8300
P198 lenalidomide pre-treatment human myeloma cell P198 lenalidomide pre-treatment human myeloma cell P198 lenalidomide pre-treatment human myeloma cell P198 lenalidomide pre-treatment
GSM212290
GPL8300
P548 lenalidomide pre-treatment human myeloma cell P548 lenalidomide pre-treatment human myeloma cell P548 lenalidomide pre-treatment human myeloma cell P548 lenalidomide pre-treatment
GSM212291
GPL8300
P72 lenalidomide pre-treatment human myeloma cell P72 lenalidomide pre-treatment human myeloma cell P72 lenalidomide pre-treatment human myeloma cell P72 lenalidomide pre-treatment
GSM212292
GPL8300
P533 lenalidomide post-treatment human myeloma cell P533 lenalidomide post-treatment human myeloma cell P533 lenalidomide post-treatment human myeloma cell P533 lenalidomide post-treatment
GSM212293
GPL8300
P533 lenalidomide pre-treatment human myeloma cell P533 lenalidomide pre-treatment human myeloma cell P533 lenalidomide pre-treatment human myeloma cell P533 lenalidomide pre-treatment
GSM212295
GPL8300
P220 lenalidomide pre-treatment human myeloma cell P220 lenalidomide pre-treatment human myeloma cell P220 lenalidomide pre-treatment human myeloma cell P220 lenalidomide pre-treatment
GSM212296
GPL8300
P616 lenalidomide post-treatment human myeloma cell P616 lenalidomide post-treatment human myeloma cell P616 lenalidomide post-treatment human myeloma cell P616 lenalidomide post-treatment
GSM212298
GPL8300
P244 lenalidomide post-treatment human myeloma cell P244 lenalidomide post-treatment human myeloma cell P244 lenalidomide post-treatment human myeloma cell P244 lenalidomide post-treatment
GSM212299
GPL8300
P318 lenalidomide pre-treatment human myeloma cell P318 lenalidomide pre-treatment human myeloma cell P318 lenalidomide pre-treatment human myeloma cell P318 lenalidomide pre-treatment
GSM212300
GPL8300
P238 lenalidomide pre-treatment human myeloma cell P238 lenalidomide pre-treatment human myeloma cell P238 lenalidomide pre-treatment human myeloma cell P238 lenalidomide pre-treatment
GSM212301
GPL8300
P0677 lenalidomide pre-treatment human myeloma cell P0677 lenalidomide pre-treatment human myeloma cell P0677 lenalidomide pre-treatment human myeloma cell P0677 lenalidomide pre-treatment
GSM212304
GPL8300
P581 lenalidomide pre-treatment human myeloma cell P581 lenalidomide pre-treatment human myeloma cell P581 lenalidomide pre-treatment human myeloma cell P581 lenalidomide pre-treatment
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes